Chemclin Diagnostics Résultats passés
Passé contrôle des critères 2/6
Chemclin Diagnostics has been growing earnings at an average annual rate of 1.8%, while the Medical Equipment industry saw earnings growing at 6.4% annually. Revenues have been declining at an average rate of 0.8% per year. Chemclin Diagnostics's return on equity is 9.9%, and it has net margins of 31.4%.
Informations clés
1.8%
Taux de croissance des bénéfices
-8.3%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 16.0% |
| Taux de croissance des recettes | -0.8% |
| Rendement des fonds propres | 9.9% |
| Marge nette | 31.4% |
| Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Recent updates
Little Excitement Around Chemclin Diagnostics Co., Ltd.'s (SHSE:688468) Earnings
Sep 28
Concerns Surrounding Chemclin Diagnostics' (SHSE:688468) Performance
May 06Little Excitement Around Chemclin Diagnostics Co., Ltd.'s (SHSE:688468) Earnings
Apr 30Chemclin Diagnostics (SHSE:688468) Shareholders Will Want The ROCE Trajectory To Continue
Mar 27Ventilation des recettes et des dépenses
Comment Chemclin Diagnostics gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 24 | 444 | 139 | 141 | 67 |
| 30 Jun 24 | 452 | 147 | 137 | 62 |
| 31 Mar 24 | 456 | 151 | 139 | 67 |
| 31 Dec 23 | 445 | 147 | 133 | 65 |
| 30 Sep 23 | 451 | 155 | 127 | 64 |
| 30 Jun 23 | 461 | 160 | 133 | 68 |
| 31 Mar 23 | 445 | 148 | 129 | 67 |
| 31 Dec 22 | 465 | 153 | 135 | 68 |
| 30 Sep 22 | 475 | 153 | 136 | 70 |
| 30 Jun 22 | 457 | 142 | 136 | 68 |
| 31 Mar 22 | 471 | 144 | 142 | 71 |
| 31 Dec 21 | 471 | 143 | 143 | 67 |
| 30 Sep 21 | 478 | 148 | 149 | 59 |
| 30 Jun 21 | 504 | 156 | 148 | 64 |
| 31 Mar 21 | 479 | 144 | 139 | 58 |
| 31 Dec 20 | 418 | 117 | 129 | 54 |
| 31 Dec 19 | 455 | 141 | 141 | 55 |
| 31 Dec 18 | 366 | -424 | 633 | 50 |
| 31 Dec 17 | 319 | -435 | 621 | 31 |
Des revenus de qualité: 688468 has high quality earnings.
Augmentation de la marge bénéficiaire: 688468's current net profit margins (31.4%) are lower than last year (34.3%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 688468 has become profitable over the past 5 years, growing earnings by 1.8% per year.
Accélération de la croissance: 688468's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: 688468 had negative earnings growth (-9.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Rendement des fonds propres
ROE élevé: 688468's Return on Equity (9.9%) is considered low.